Biomarkers for Comorbidities Modulate the Activity of T-Cells in COPD
In smoking-induced chronic obstructive pulmonary disease (COPD), various comorbidities are linked to systemic inflammation and infection-induced exacerbations. The underlying mechanisms are unclear but might provide therapeutic targets. T-cell activity is central in systemic inflammation and for inf...
Main Authors: | Kaschin Jamal Jameel, Willem-Jakob Gallert, Sarah D. Yanik, Susanne Panek, Juliane Kronsbein, David Jungck, Andrea Koch, Jürgen Knobloch |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/13/7187 |
Similar Items
-
Comorbidities and COPD severity in a clinic-based cohort
by: Chantal Raherison, et al.
Published: (2018-07-01) -
Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study
by: Youngmee Kim, et al.
Published: (2021-05-01) -
Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)—Current Considerations for Clinical Practice
by: Frederik Trinkmann, et al.
Published: (2019-01-01) -
The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
by: Wacker ME, et al.
Published: (2017-12-01) -
Influence of Comorbidities on the Survival of COPD Patients According to Phenotypes
by: Ji Z, et al.
Published: (2020-10-01)